Delivery Order SPE2DB22D3010-SPE2DB24FP0SC
- Not listed
- This federal contract award is for the delivery of Moderna COVID-19 vaccine doses (0.25 mL) for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA). The $1,476.88 firm-fixed-price Delivery Order was awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA), a major U.S. Department of Defense (DoD) agency responsible for providing logistics and acquisition support to the U.S. Armed Forces. Amerisourcebergen, a large...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The $2,215.32 firm-fixed-price contract is a delivery order without a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will provide the 0.25 mL vaccine doses to support the DLA's mission of supplying medical commodities to the...
- This contract award is for the delivery of Moderna COVID-19 vaccines (0.25 mL) for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The contract, valued at $3,797.30, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This is a firm fixed price delivery order contract that does not have a...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a $2,215.32 firm-fixed-price delivery order to supply Moderna COVID-19 vaccines for children aged 6 months to 11 years under the Emergency Use Authorization. This contract has no set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of Moderna COVID-19 vaccines for children aged 6 months to 11 years under the Emergency Use Authorization (EUA). The contract has a ceiling value of $2,544.44 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that holds substantial Indefinite Delivery Contracts (IDCs) with the DLA and the Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Moderna COVID-19 vaccines for the 6 month to 11 year old age group under the Emergency Use Authorization (EUA). The contract is a firm fixed-price delivery order with a ceiling value of $1,290.00 and a period of performance through March 13, 2025. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award, valued at $4,556.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). This is a firm-fixed-price contract with a completion date of November 13, 2023. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Moderna COVID-19 vaccines for ages 6 months to 11 years old under an Emergency Use Authorization (EUA). The contract is a $4,752.75 firm fixed-price delivery order with an ultimate completion date of April 8, 2025. The contract is not a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The $1,476.88 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary supplier of pharmaceutical and medical products to the Department of Defense (DoD) and other government agencies. This...
- This federal contract award, ID SPE2DB20D7059, is a delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of Moderna COVID-19 vaccines in the 6-month to 11-year age group under the Emergency Use Authorization (EUA). The $3,797.30 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on November 1, 2023, with a completion date of November 24, 2023. Amerisourcebergen is a major pharmaceutical distributor that...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB24FP0SCDelivery Order
This federal contract award is for the delivery of Moderna COVID-19 vaccines for children aged 6 months to 11 years old, under the Emergency Use Authorization (EUA). The contract, valued at $4,556.76, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 6, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, primarily serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 10/16/23 |